Recent YSCC Discoveries

A Yale School of Medicine study introduces new technology that allows researchers to examine where gene activity is happening in a tissue and what proteins are present and where, all on a single sample.

Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable autoimmune disease marked by joint inflammation and subsequent damage. Despite advances in treatment, such as targeted immunotherapies, joint erosion persists even during disease remission. A new Yale study explains the cellular underpinnings of this ongoing joint destruction.

The gift is a commitment to advancing medical research in multiple sclerosis and it's rooted in gratitude to David Hafler, MD.

Members of the Center for Breast Cancer and the Hematology Program at Yale Cancer Center and Smilow Cancer Hospital recently presented their latest groundbreaking research on two national stages. First at the annual American Society of Hematology (ASH) meeting, followed by the annual San Antonio Breast Cancer Symposium (SABCS).

For Erica Herzog, MD, PhD, being a mentor is a privilege that is immensely fulfilling. This summer, two of Herzog’s mentees met career benchmarks, and both credit Herzog and her guidance for getting them there.

The Office of Academic & Professional Development (OAPD) will hold faculty workshops on Wednesday, Jan. 14 and Jan. 28, and the next wellness webinar on Wednesday, Jan. 21. Register today!

Physicians, scientists, and trainees from Yale Cancer Center and Smilow Cancer Hospital attended the 67th annual meeting of the American Society of Hematology in Orlando, FL, December 6-9, 2025 to present the latest advances in hematological research and clinical care from Yale.

In a Q&A, trailblazing chemist Craig Crews discusses the transformative science emerging from Yale—and why translating innovative ideas into real-world businesses is good for the university and New Haven.

At the 2025 ASH Annual Meeting, Yale Cancer Center experts will present new findings in key areas from vaccine effectiveness to new biomarkers and therapies for blood diseases.